Home
    Disclaimer
    ๐Ÿงช This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    2C-T-21

    Aliases: Aurora

    Summary TheDrug.Wiki TripSit PsychonautWiki

    2,5-Dimethoxy-4-ethylfluorothiophenethylamine (also known as 2C-T-21, or colloquially as Aurora) is a psychedelic substance of the phenethylamine chemical class that produces psychedelic effects when administered. It is a member of the 2C-x family of psychedelic phenethylamines, all of which were derived from the systematic modification of the mescaline molecule. 2C-T-21 was first synthesized by Alexander Shulgin and documented in his book PiHKAL ("Phenethylamines I Have Known and Loved").

    Perspectives

    “I noticed something undefined within five minutes which went away. Within 15 minutes I noticed a definite awareness of activity. There was a progressive increase in awareness of something happening over the next two hours with a plateau of perhaps an hour then occurring. The nature of the happening, as usual, was not clear. During the experience I was more talkative than I usually am. I seemed to be interacting with all others. There was no euphoria but, then, there was no body load or nausea, nor was there any nystagmus. I found a little mental confusion at the peak and there was some searching in my memory bank for the right chips at times. I lost the entire line of one of my conversations at one point during the plateau and had to ask what I was talking about. I tested my visual field on a painting and with sufficient concentration I could get the center part to wiggle a little. I didnโ€™t try to observe anything with my eyes closed. I feel that there was something physical about the eyes. In the evening, after-images were quite intense, and the next day my eyes seemed tired or bothered. What can I say? The material was pleasant and I certainly got the feeling of being high but not getting too much out of it. There were no insights or โ€œah-hahs.”

    Dose Information TheDrug.Wiki TripSit PsychonautWiki

    ROA Light Common Strong Heavy
    Oral 5-10mg 10-12mg 12-15mg 15mg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit PsychonautWiki

    ROA Onset Comeup Peak Offset After Effects Total
    Oral 15-40 min 30-60 min 2-5 hrs 2-4 hrs 2-12 hrs 4.8-10.7 hrs
    Insufflated 5-15 min 15-30 min 2-5 hrs 2-4 hrs 2-12 hrs 4.3-9.8 hrs

    Effect Profile

    28 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Validated against 20 Erowid trip reports
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Psychedelic 8.8
    Intense+ 9/10

    Strong visuals, headspace, auditory effects, and body load

    Visual Intensity ×3
    10
    color enhancement tracers drifting visual enhancement pattern recognition enhancement color shifting +3 more
    Headspace Depth ×3
    10
    conceptual thinking emotion enhancement personal bias suppression time distortion confusion
    Auditory Effects ×1
    10
    auditory distortion
    Body Load / Somatic Effects ×1
    10
    temperature regulation suppression nausea muscle tension teeth grinding increased heart rate

    Tolerance

    Build-up develops rapidly after a single use (serotonergic psychedelic)
    Reset 7โ€“14 days for baseline

    Effects Erowid Bluelight

    Aggregated from 20 Erowid and 8 Bluelight experience reports

    Positive Effects 37

    Stimulation 57.1% 81%
    Tactile Enhancement 53.6% 88%
    Euphoria 46.4% 84%
    Introspection 46.4% 82%
    Music Enhancement 42.9% 93%
    Empathy 39.3% 78%
    Mood Lift 37.5% 87%
    Focus Enhancement 35.0% 70%
    Color Enhancement 32.1% 88%
    Analysis Enhancement 25.0% 81%
    Sociability Enhancement 25.0% 80%
    Patterning 25.0% 82%
    Joy 25.0% 85%
    Thought Acceleration 25.0% 80%
    Tactile Intimacy Enhancement 25.0% 86%
    Body High 21.4% 88%
    Closed-Eye Visuals 14.3% 93%
    Tingling 12.5% 85%
    Love 12.5% 90%
    Warmth 12.5% 88%

    Adverse Effects 17

    Nausea 42.9% 85%
    Thought Disorganization 37.5% 76%
    Auditory Effects 28.6% 80%
    Body Load 25.0% 69%
    Anxiety 25.0% 88%
    Jaw Clenching 21.4% 90%
    Muscle Tension 21.4% 80%
    Pupil Dilation 20.0% 70%
    Confusion 15.0% 70%
    Paranoia 12.5% 85%
    Restlessness 12.5% 82%
    Loneliness 12.5% 85%
    Dysphoria 12.5% 78%
    Insomnia 12.5% 80%
    Headache 12.5% 85%
    Sweating 12.5% 85%
    Field Narrowing 12.5% 75%

    Combinations TripSit

    PiHKAL / TiHKAL Shulgin

    PiHKAL #49: 2C-T-21

    “I noticed something undefined within five minutes which went away. Within 15 minutes I noticed a definite awareness of activity. There was a progressive increase in awareness of something happening over the next two hours with a plateau of perhaps an hour then occurring. The nature of the happening, as usual, was not clear. During the experience I was more talkative than I usually am. I seemed to be interacting with all others. There was no euphoria but, then, there was no body load or nausea, nor was there any nystagmus. I found a little mental confusion at the peak and there was some searching in my memory bank for the right chips at times. I lost the entire line of one of my conversations at one point during the plateau and had to ask what I was talking about. I tested my visual field on a painting and with sufficient concentration I could get the center part to wiggle a little. I didnโ€™t try to observe anything with my eyes closed. I feel that there was something physical about the eyes. In the evening, after-images were quite intense, and the next day my eyes seemed tired or bothered. What can I say? The material was pleasant and I certainly got the feeling of being high but not getting too much out of it. There were no insights or โ€œah-hahs.”

    โ€” Alexander Shulgin, PiHKAL (with 6 mg)

    Helpful Links